Role of Nitric Oxide Synthases in Early Blood-brain Barrier Disruption Following Transient Focal Cerebral Ischemia
Overview
Affiliations
The role of nitric oxide synthases (NOSs) in early blood-brain barrier (BBB) disruption was determined using a new mouse model of transient focal cerebral ischemia. Ischemia was induced by ligating the middle cerebral artery (MCA) at its M2 segment and reperfusion was induced by releasing the ligation. The diameter alteration of the MCA, arterial anastomoses and collateral arteries were imaged and measured in real time. BBB disruption was assessed by Evans Blue (EB) and sodium fluorescein (Na-F) extravasation at 3 hours of reperfusion. The reperfusion produced an extensive vasodilation and a sustained hyperemia. Although expression of NOSs was not altered at 3 hours of reperfusion, L-NAME (a non-specific NOS inhibitor) abolished reperfusion-induced vasodilation/hyperemia and significantly reduced EB and Na-F extravasation. L-NIO (an endothelial NOS (eNOS) inhibitor) significantly attenuated cerebral vasodilation but not BBB disruption, whereas L-NPA and 7-NI (neuronal NOS (nNOS) inhibitors) significantly reduced BBB disruption but not cerebral vasodilation. In contrast, aminoguanidine (AG) (an inducible NOS (iNOS) inhibitor) had less effect on either cerebral vasodilation or BBB disruption. On the other hand, papaverine (PV) not only increased the vasodilation/hyperemia but also significantly reduced BBB disruption. Combined treatment with L-NAME and PV preserved the vasodilation/hyperemia and significantly reduced BBB disruption. Our findings suggest that nNOS may play a major role in early BBB disruption following transient focal cerebral ischemia via a hyperemia-independent mechanism.
Faber J J Cereb Blood Flow Metab. 2025; :271678X251322378.
PMID: 40072222 PMC: 11904929. DOI: 10.1177/0271678X251322378.
The Influence of Oxidative Stress Markers in Patients with Ischemic Stroke.
Pawluk H, Tafelska-Kaczmarek A, Soponska M, Porzych M, Modrzejewska M, Pawluk M Biomolecules. 2024; 14(9).
PMID: 39334896 PMC: 11430825. DOI: 10.3390/biom14091130.
Plasminogen activator inhibitor-1 mediates cerebral ischemia-induced astrocytic reactivity.
Yanev P, Martin-Jimenez C, Vesga-Jimenez D, Zvinys L, Weinrich N, Cree M J Cereb Blood Flow Metab. 2024; 45(1):102-114.
PMID: 39113414 PMC: 11572231. DOI: 10.1177/0271678X241270445.
Anti-Neuroinflammatory Effects of on LPS-Stimulated BV2 Cells.
Cho H, Kim D, Oh J, Park S, Kweon B, Bae G Curr Issues Mol Biol. 2024; 46(1):884-895.
PMID: 38275670 PMC: 10814974. DOI: 10.3390/cimb46010056.
Kho J, Polak U, Jiang M, Odom J, Hunter J, Ali S JCI Insight. 2023; 8(17).
PMID: 37490345 PMC: 10544197. DOI: 10.1172/jci.insight.168475.